Product Information
PROPRANOLOL ER 120 MG CAPSULE is a generic product labeled by Lannett Company Inc., priced at $0.1956 per EA under NDC 00527411837. Its NADAC has been published 298 times since Jan 20, 2021.
FDA first approved this application on Jan 6, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
120 mg/1
Manufacturer
Lannett Company Inc.NDC
00527411837
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PROPRANOLOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212026FDA Approved
1/6/2020
TE Code
AB
On Market Since
1/6/2020
Pharmacological Classes
Price Statistics
The NADAC for PROPRANOLOL ER 120 MG CAPSULE has been published 298 times since Jan 20, 2021, and over the history we have for it it has declined 61.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1956 per EA |
|---|---|
| All-time high | $0.6028 (Mar 10, 2021) |
| All-time low | $0.1620 (May 22, 2024) |
| 52-week high | $0.2075 |
| 52-week low | $0.1858 |
| Median price | $0.2210 |
| Average price | $0.2788 |
| Largest weekly change | -32.4% (Jul 20, 2022) |
| Weeks tracked | 298 |
| Tracking since | Jan 20, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lannett Company Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
propranolol hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROPRANOLOL ER 120 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PROPRANOLOL ER 120 MG CAPSULE, manufactured by Lannett Company Inc., is $0.1956 per EA (NDC 00527411837), effective Sep 30, 2026.
How has the price of PROPRANOLOL ER 120 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PROPRANOLOL ER 120 MG CAPSULE has declined 61.2%. It has been tracked across 298 weekly CMS publications since Jan 20, 2021.
What are the highest and lowest recorded NADAC prices for PROPRANOLOL ER 120 MG CAPSULE?
Since Jan 20, 2021, the NADAC for PROPRANOLOL ER 120 MG CAPSULE has ranged from a low of $0.1620 (May 22, 2024) to a high of $0.6028 (Mar 10, 2021), with a median of $0.2210 per EA.
Are there cheaper alternatives to PROPRANOLOL ER 120 MG CAPSULE?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PROPRANOLOL ER 120 MG CAPSULE, is $0.1839 per EA — about 6% below PROPRANOLOL ER 120 MG CAPSULE.
Who manufactures PROPRANOLOL ER 120 MG CAPSULE?
PROPRANOLOL ER 120 MG CAPSULE (NDC 00527411837) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.